PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsPruritus
MeSH D011537 - pruritus
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012871:Skin diseases
35 Companies
17 Drugs
$
Success rate
D012877:Skin manifestations
0 Companies
0 Drugs
Success rate
D011537: 
Pruritus
109 Companies
32 Drugs
$
Success rate
D011538:Pruritus ani
113 Companies
30 Drugs
$
Success rate
D011539:Pruritus vulvae
0 Companies
0 Drugs
Success rate
D014008:Tinea pedis
59 Companies
17 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaDoxepin Doxepin  1987-11-09   
Fluocinonide Fluocinonide  1989-02-06   
Fluocinonide Fluocinonide Emulsified Base  1989-02-07   
Hydroxyzine Hy-pam  1985-03-04   
Hydroxyzine Hydroxyzine  1982-01-01   
Hydroxyzine Hydroxyzine Pamoate  1982-03-05   
Novast LaboratoriesCyproheptadine Cyproheptadine  2015-09-23   
PadagisFluocinolone acetonide Fluocinolone  2013-08-09   
Fluocinonide Fluocinonide  2014-01-14   
Mometasone furoate Mometasone Furoate  2002-03-18   
Taro PharmaceuticalDoxepin Doxepin  2020-07-01   
Fluocinolone acetonide Fluocinolone  1994-10-31   
Fluocinonide Fluocinonide  1987-06-10   
Fluocinonide Fluocinonide Emulsified Base  1989-01-19   
Mometasone furoate Mometasone Furoate  2004-12-03   
Glenmark PharmaceuticalsFluocinolone acetonide Fluocinolone  2018-10-25   
Fluocinolone acetonide, Fluocinonide Fluocinonide  2018-10-26   
Mometasone furoate Mometasone Furoate  2008-05-28   
Olopatadine, Mometasone furoate Ryaltris 2034-09-04 2022-01-13   
MylanCyproheptadine Cyproheptadine  1982-01-01   
Doxepin Doxepin  1986-05-13   
Hydrocortisone, Pramoxine Epifoam  1982-01-01   
Hydrocortisone, Pramoxine Proctofoam  1982-01-01   
Doxepin Zonalon  1994-04-01   
XiromedFluocinonide Fluocinonide  2019-11-26   
1
2
3
4
5
6
...
11
>
Clinical Trials
Historical Success Rate
Phase 1
61%
11/18
Phase 2
41%
17/41
Phase 3
75%
30/40
Approved: 21Overall Success rate: 19%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Hydroxyzine
Padagis
Halobetasol,
Mometasone furoate
Glenmark Pharmaceuticals
Mometasone furoate,
Olopatadine
Mayne Group
Halobetasol
Organon
Formoterol,
Formoterol fumarate,
Mometasone furoate,
Hydroxyzine,
Nepidermin
1
2
3
4
5
6
...
8
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use